Protalix BioTherapeutics, Inc.
PLX
$1.69
$0.020.90%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 29.37M | 33.40M | 34.74M | 34.83M | 27.41M |
| Total Receivables | 14.43M | 9.44M | 4.68M | 3.40M | 2.20M |
| Inventory | 21.26M | 21.13M | 19.51M | 21.24M | 17.20M |
| Prepaid Expenses | -- | -- | -- | 500.00K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.45M | 1.51M | 1.59M | 110.00K | 1.05M |
| Total Current Assets | 66.50M | 65.49M | 60.51M | 60.08M | 47.85M |
|
|
|||||
| Total Current Assets | 66.50M | 65.49M | 60.51M | 60.08M | 47.85M |
| Net Property, Plant & Equipment | 12.53M | 9.74M | 9.95M | 10.02M | 10.29M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.23M | 3.26M | 3.43M | 3.32M | 3.42M |
| Total Assets | 82.26M | 78.49M | 73.89M | 73.42M | 61.56M |
|
|
|||||
| Total Accounts Payable | 5.38M | 6.69M | 4.12M | 4.53M | 3.14M |
| Total Accrued Expenses | 11.64M | 11.81M | 14.87M | 13.80M | 11.88M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.40M | 1.47M | 1.43M | 1.50M | 1.51M |
| Total Finance Division Other Current Liabilities | 3.54M | 4.12M | 3.90M | 5.79M | 7.70M |
| Total Other Current Liabilities | 3.54M | 4.12M | 3.90M | 5.79M | 7.70M |
| Total Current Liabilities | 21.95M | 24.09M | 24.32M | 25.62M | 24.22M |
|
|
|||||
| Total Current Liabilities | 21.95M | 24.09M | 24.32M | 25.62M | 24.22M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.78M | 3.88M | 3.81M | 4.03M | 4.18M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 631.00K | 615.00K | 551.00K | 559.00K | 730.00K |
| Total Liabilities | 29.36M | 28.58M | 28.68M | 30.21M | 29.13M |
|
|
|||||
| Common Stock & APIC | 432.40M | 431.75M | 427.22M | 421.60M | 417.32M |
| Retained Earnings | -379.49M | -381.85M | -382.01M | -378.39M | -384.89M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 52.91M | 49.90M | 45.21M | 43.21M | 32.44M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 52.91M | 49.90M | 45.21M | 43.21M | 32.44M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 52.91M | 49.90M | 45.21M | 43.21M | 32.44M |
|
|
|||||